PL1655030T3 - Pochodne benzotiadiazyny, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne - Google Patents

Pochodne benzotiadiazyny, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne

Info

Publication number
PL1655030T3
PL1655030T3 PL05292310T PL05292310T PL1655030T3 PL 1655030 T3 PL1655030 T3 PL 1655030T3 PL 05292310 T PL05292310 T PL 05292310T PL 05292310 T PL05292310 T PL 05292310T PL 1655030 T3 PL1655030 T3 PL 1655030T3
Authority
PL
Poland
Prior art keywords
same
pharmaceutical compositions
compositions containing
benzothiadiazine derivatives
preparing
Prior art date
Application number
PL05292310T
Other languages
English (en)
Inventor
Patrice Desos
Alexis Cordi
Pierre Lestage
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of PL1655030T3 publication Critical patent/PL1655030T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
PL05292310T 2004-11-03 2005-11-02 Pochodne benzotiadiazyny, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne PL1655030T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0411690A FR2877338B1 (fr) 2004-11-03 2004-11-03 Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP05292310A EP1655030B1 (fr) 2004-11-03 2005-11-02 Dérivés de benzothiadiazine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
PL1655030T3 true PL1655030T3 (pl) 2008-03-31

Family

ID=34950935

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05292310T PL1655030T3 (pl) 2004-11-03 2005-11-02 Pochodne benzotiadiazyny, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne

Country Status (26)

Country Link
US (2) US7268130B2 (pl)
EP (1) EP1655030B1 (pl)
JP (1) JP2006151972A (pl)
KR (1) KR100818431B1 (pl)
CN (1) CN100396673C (pl)
AR (1) AR051149A1 (pl)
AT (1) ATE381338T1 (pl)
AU (1) AU2005229698A1 (pl)
BR (1) BRPI0504780A (pl)
CA (1) CA2524859A1 (pl)
DE (1) DE602005003907D1 (pl)
DK (1) DK1655030T3 (pl)
EA (1) EA011212B1 (pl)
ES (1) ES2298970T3 (pl)
FR (1) FR2877338B1 (pl)
GE (1) GEP20074256B (pl)
HR (1) HRP20080119T5 (pl)
MA (1) MA27917A1 (pl)
MX (1) MXPA05011820A (pl)
NO (1) NO20055167L (pl)
NZ (1) NZ543358A (pl)
PL (1) PL1655030T3 (pl)
PT (1) PT1655030E (pl)
SG (1) SG121999A1 (pl)
SI (1) SI1655030T1 (pl)
ZA (1) ZA200508911B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008510835A (ja) * 2004-08-25 2008-04-10 エッセンシャリス,インク. カリウムatpチャンネル開放因子の製剤処方、及びその使用
WO2007081521A2 (en) 2006-01-05 2007-07-19 Essentialis, Inc. Salts of potassium atp channel openers and uses thereof
CN101795691A (zh) * 2007-07-02 2010-08-04 伊森舍丽斯有限公司 钾atp通道开放剂的盐及其用途
US8124793B2 (en) * 2007-11-27 2012-02-28 Gail Marie Cronyn, legal representative Derivatives of ethylene methanedisulfonate as cancer chemotherapeutic agents
FR2943342B1 (fr) * 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010111518A1 (en) * 2009-03-27 2010-09-30 Yale University Treatment and prevention of white matter injury with katp channel activators
FR2955106B1 (fr) * 2010-01-08 2011-12-23 Servier Lab Nouveaux derives de benzothiadiazines cyclopropylees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR101633632B1 (ko) 2015-09-30 2016-06-27 김동용 방사능 차폐재

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722502B1 (fr) 1994-07-12 1996-08-23 Adir Nouveau derive de benzothiadiazine, son procede depreparation et les compositions pharmaceutiques qui le contiennent
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
RU2214405C2 (ru) 1998-02-18 2003-10-20 НьюроСёрч А/С Новые соединения и их применение в качестве положительных модуляторов амра-рецепторов
FR2801587B1 (fr) * 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2833956B1 (fr) * 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2833950B1 (fr) * 2001-12-21 2005-12-16 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
EP1655030B1 (fr) 2007-12-19
SG121999A1 (en) 2006-05-26
DK1655030T3 (da) 2008-04-28
HRP20080119T5 (en) 2008-10-31
EA011212B1 (ru) 2009-02-27
MXPA05011820A (es) 2006-05-08
GEP20074256B (en) 2007-12-10
CN1775767A (zh) 2006-05-24
FR2877338A1 (fr) 2006-05-05
ES2298970T3 (es) 2008-05-16
NO20055167L (no) 2006-05-04
FR2877338B1 (fr) 2007-01-26
AU2005229698A1 (en) 2006-05-18
EA200501530A1 (ru) 2006-06-30
ZA200508911B (en) 2006-07-26
NZ543358A (en) 2007-04-27
CN100396673C (zh) 2008-06-25
US7268130B2 (en) 2007-09-11
AR051149A1 (es) 2006-12-20
JP2006151972A (ja) 2006-06-15
ATE381338T1 (de) 2008-01-15
KR100818431B1 (ko) 2008-04-01
CA2524859A1 (fr) 2006-05-03
US20070270415A1 (en) 2007-11-22
NO20055167D0 (no) 2005-11-03
MA27917A1 (fr) 2006-06-01
SI1655030T1 (sl) 2008-04-30
US20060094712A1 (en) 2006-05-04
DE602005003907D1 (de) 2008-01-31
PT1655030E (pt) 2008-02-08
KR20060052410A (ko) 2006-05-19
HRP20080119T3 (en) 2008-04-30
EP1655030A1 (fr) 2006-05-10
BRPI0504780A (pt) 2006-06-27

Similar Documents

Publication Publication Date Title
IL164798A0 (en) Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
IL185353A0 (en) Azabicycloalkane derivatives , pharmaceutical compositions containing the same and methods for the preparation thereof
IL180108A (en) Sulfamate and Sulfamide Derivatives, Pharmaceutical Preparations Containing Them, Processes for their Preparation
IL193772A0 (en) 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
IL169500A0 (en) Pyrrolopyridazine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL183105A0 (en) 4-arylamino pyridone derivatives and pharmaceutical compositions containing them
IL181022A0 (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same
IL173195A0 (en) Cyclovinylazoline derivatives, their preparation and pharmaceutical compositions containing them
HUP0500170A3 (en) Piperazine derivatives, process for producing them and pharmaceutical compositions containing them
IL187713A0 (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
IL186062A0 (en) Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
PL1720544T3 (pl) Nowe pochodne azabicykliczne, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne
IL187391A0 (en) Thiazole derivatives, their preparation and use and pharmaceutical compositions containing them
HUP0401522A2 (en) New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
HUP0401523A2 (en) Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them
IL181730A0 (en) Benzodiazinone derivatives and pharmaceutical compositions containing the same
TWI315305B (en) Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof
IL163643A0 (en) Oxazolidinone derivatives, processes for their forpreparation, and pharmaceutical compositions containing them
IL190596A0 (en) 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
SI1655030T1 (sl) Derivati benzotiadiazina, postopek za pripravo le-teh in farmacevtski sestavki, ki jih vsebujejo
IL177806A0 (en) Crystalline clopidogrel naphthalenesulfonate, a method for preparing the same and pharmaceutical compositions containing the same
IL190861A0 (en) Novel indolizine derivatives, method for preparing same and therapeutic compositions comprising same
HUP0401524A2 (en) New benzoyl urea derivatives, process for their preparation, their use and pharmaceutical compositions containing them
SG113569A1 (en) New flourinated benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
IL176993A0 (en) Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof